EmpNia Inc.

EmpNia Inc. is a medical device company specializing in precision image-guided radiation therapy (IGRT) motion management. The company manufactures EmpNia eMotus, an FDA-cleared wearable fiber optic sensing solution designed to dynamically track and manage respiratory motion during cancer treatment. The eMotus system combines a wearable fiber optic sensor with integrated software to enable real-time patient motion detection, ensuring consistent and confident treatment delivery across diverse patient presentations. The technology is system-agnostic and universally compatible with existing radiation therapy platforms, requiring no capital equipment purchase—operational on a service model. Key features include fast seamless integration into clinical workflows, cost-effective deployment, and closed-loop feedback to radiation oncology teams. The solution addresses a critical clinical need in precision oncology by reducing treatment uncertainty due to respiratory motion, thereby improving targeting accuracy and patient safety. EmpNia targets radiation oncology departments and cancer treatment centers seeking advanced motion management capabilities without substantial infrastructure investment.